NCT04158336 2026-03-18
A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1 Completed
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
BeOne Medicines
Children's National Research Institute
M.D. Anderson Cancer Center
Chugai Pharmaceutical
Georgetown University
Eisai Inc.
Zhejiang University
Axcynsis Therapeutics Pte Ltd
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Gilead Sciences
Boundless Bio, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ono Pharmaceutical Co. Ltd
RemeGen Co., Ltd.
Guangzhou Virotech Pharmaceutical Co., Ltd.